Uptake and Metabolism of Tritiated Norepinephrine in the Isolated Canine Heart

Using an isolated canine heart preparation, the myocardial norepinephrine pool was labeled by injecting tritiated norepinephrine into the blood perfusing the heart. The extraction of the norepinephrine during a single circulation through the coronary bed was shown to be large (74%). As the isotopic material, which was extracted, was released spontaneously from the norepinephrine pool 75% to 88% of it was metabolized before appearing in the coronary venous blood. The chief metabolite has been demonstrated to be normetanephrine which accounts for 39.0% to 61.7% of the spontaneously released norepinephrine. Because of this it is concluded that catechol-O-methyl transferase is the enzyme primarily responsible for the metabolic inactivation of norepinephrine in the canine heart. When release was increased by the injection of tyramine, more of the released norepinephrine appeared unmetabolized in coronary venous blood, suggesting that the enzymatic process by which norepinephrine is inactivated may be limited. Therefore, the extent to which enzymatic processes contribute to the termination of augmented adrenergic activity in the heart may be questioned.

[1]  N. D. Goldberg,et al.  Species differences in the cardiac effects of a monoamine oxidase inhibitor. , 1962, The Journal of pharmacology and experimental therapeutics.

[2]  E. Braunwald,et al.  Release of Norepinephrine from the Heart by Vasoactive Amines , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  J. Axelrod,et al.  Effect of drugs on the uptake and metabolism of H3-norepinephrine. , 1961, The Journal of pharmacology and experimental therapeutics.

[4]  J. Johnson,et al.  Passage of organic bases into human red cells. , 1961, The Journal of pharmacology and experimental therapeutics.

[5]  S. Udenfriend,et al.  Norepinephrine metabolism in rat brain and heart. , 1961, The Journal of pharmacology and experimental therapeutics.

[6]  S. Kety,et al.  Metabolism of 7-H3-epinephrine-d-bitartrate in normal young men. , 1961, The Journal of clinical investigation.

[7]  J. Axelrod,et al.  Lack of Uptake of Catecholamines after Chronic Denervation of Sympathetic Nerves , 1961, Nature.

[8]  George A. Bray,et al.  A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter , 1960 .

[9]  J. Axelrod,et al.  Effect of Cocaine on the Disposition of Noradrenaline labelled with Tritium , 1960, Nature.

[10]  H. Weil-Malherbe The fluorimetric estimation of catechol compounds by the ethylenediamine condensation method. , 1959, Pharmacological reviews.

[11]  A. Davison Physiological role of monoamine oxidase. , 1958, Physiological reviews.

[12]  J. Axelrod,et al.  Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.

[13]  F. Chinard,et al.  Transcapillary exchange of water and of other substances in certain organs of the dog. , 1955, The American journal of physiology.

[14]  R. E. Shipley,et al.  An Improved Recording Rotameter , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  U. V. von Euler,et al.  Noradrenaline output in urine after infusion in man. , 1951, British journal of pharmacology and chemotherapy.

[16]  U. Trendelenburg The supersensitivity caused by cocaine. , 1959, The Journal of pharmacology and experimental therapeutics.

[17]  K. Shaw,et al.  3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. , 1957, Biochimica et biophysica acta.